Labcorp projects upbeat annual profit on strong diagnostic test demand
Labcorp expects 2026 earnings to exceed estimates as demand for diagnostic tests remains high. The company also beat quarterly profit targets earlier today.
Insights:
Labcorp Holdings Inc. announced on Tuesday, February 17, 2026, that it has revised its 2026 financial outlook, forecasting annual adjusted profit above Wall Street estimates. The company, which operates primarily in the US 
US, cited robust demand for diagnostic tests as the primary driver for the updated guidance. This revision places the company’s adjusted earnings per share (EPS) midpoint above the average expectations of analysts, reflecting ongoing revenue and market-share expansion in laboratory diagnostics.
US, cited robust demand for diagnostic tests as the primary driver for the updated guidance. This revision places the company’s adjusted earnings per share (EPS) midpoint above the average expectations of analysts, reflecting ongoing revenue and market-share expansion in laboratory diagnostics.
